COVID-19 Notice: We are providing FREE consultations via phone or video conferencing for your safety and convenience. Learn More »

Pradaxa Lawsuit Update: May, 2012

The number of federal Pradaxa lawsuits filed against Boehringer Ingelheim Pharmaceuticals has risen to 18 after 8 more lawsuits were filed. The claims in these lawsuits are quite simple: Boehringer Ingelheim should have known that the risks of Pradaxa included life threatening bleeds and warn doctors accordingly.

I say “warn doctors” because that is the most accurate way to state the legal standard. But it is a little more complicated than just warning doctors. As part of Boehringer Ingelheim’s marketing of Pradaxa, it send out direct-to-consumer advertising campaigns that were designed to influence patients to go to their doctors to request Pradaxa. Plaintiffs allege in the Pradaxa lawsuits that in the course of these direct to consumer advertisements, Boehringer Ingelheim exaggerated how great of a product Pradaxa was in preventing stroke and systemic embolism, but didn’t tell patients what they need to know; there is no way to reverse the anticoagulation effects of Pradaxa, and that this irreversibility could have permanently disabling, life-threatening and fatal consequences.


Our firm is handling Pradaxa wrongful death lawsuits. If you have lost someone you love, call 800-553-8082 to discuss your potential claim or get a free online consultation. You can find the most recent Pradaxa lawsuit update here.

Contact Information